- Does KDIGO (Clinical Practice Guideline for Glomerulonephritis) represent a change in the diagnosis and treatment of glomerulonephritis?2013 | Faculty of Medicine in Hradec Králové
- Practice guideline and trends for immunosuppressive treatment of glomerulonephritides according to KDIGO (Clinical Practice Guideline for Glomerulonephritis)2013 | Second Faculty of Medicine
- Glomerulonephritis +2Publication without faculty affiliation
- Glomerulonephritis2005 | Second Faculty of Medicine
- Occurance of glomerulonephritis in the elderlyPublication without faculty affiliation
- Coxielle burnetii - the cause endocarditis compicated glomerulonephritisPublication without faculty affiliation
- Subconjunctival suffusion in acute glomerulonephritis2023 | Faculty of Medicine in Pilsen, Central Library of Charles University
- Acute postinfectious glomerulonephritis: one disease with many faces2021 | Second Faculty of Medicine
- Recurrence of primary glomerulonephritis after renal transplantation2021 | Central Library of Charles University
- Biological Treatment of glomerulonephritis2013 | First Faculty of Medicine
- Rituximab in the chronic glomerulonephritis2010 | First Faculty of Medicine
- KDIGO clinical practice guideline for glomerulonephritis - which of them are most important for the clinical practice2012 | First Faculty of Medicine
- Glomerulonephritis in pediatric practice - most frequent clinical units, etiopathogenesis, therapy and prognosis2006 | Second Faculty of Medicine
- Antineutrophil Cytoplasmic Autoantibody-Associated Glomerulonephritis as a Complication of Home Parenteral Nutrition2022 | Publication without faculty affiliation
- Nephrotic syndrome, primary glomerulonephritis, secondary glomerulopaty2010 | First Faculty of Medicine
- KDIGO guedlines for the diagnosis and treatment glomerulonephritis, What´s new? Commentary on:KI 2,212,139-2742012 | First Faculty of Medicine
- Rapidly progressive glomerulonephritis - innovations in therapy2015 | First Faculty of Medicine
- One opinion about immunosupressive therapy of chronic primary glomerulonephritis2009 | Second Faculty of Medicine
- C4 nephritic factor in patients with immune-complex-mediated membranoproliferative glomerulonephritis and C3-glomerulopathy2019 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Pilsen
- Rapidly progression of glomerulonephritis2006 | First Faculty of Medicine
- FHR-5 Serum Levels and CFHR5 Genetic Variations in Patients With Immune Complex-Mediated Membranoproliferative Glomerulonephritis and C3-Glomerulopathy2021 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Pilsen
- Biological therapy of glomerulonephritis2007 | First Faculty of Medicine
- Clinical Factors and Adverse Kidney Outcomes in Children With ANCA-Associated Glomerulonephritis2023 | Second Faculty of Medicine
- Validation of distinct pathogenic patterns in a cohort of membranoproliferative glomerulonephritis patients by cluster analysis2020 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Pilsen
- Diagnosis and treatment of chronic glomerulonephritis2001 | First Faculty of Medicine
- Secondary causes of membranous glomerulonephritis (1)2004 | First Faculty of Medicine
- Developments in the Histopathological Classification of ANCA-Associated Glomerulonephritis2020 | First Faculty of Medicine
- Proteinase-3 and myeloperoxidase serotype in relation to demographic factors and geographic distribution in anti-neutrophil cytoplasmic antibody-associated glomerulonephritis2019 | First Faculty of Medicine